DKR Capital

DKR Capital was a U.S.-based investment management firm and hedge fund manager, not an operating biotechnology, pharmaceutical, or healthcare company. It appears to have provided investment advisory and asset management services to high-net-worth individuals, family offices, and institutional investors, with some evidence of healthcare-focused investing through personnel biographies and activist positions in biotechnology companies. Public regulatory records indicate DKR Capital Partners L.P.'s SEC investment adviser registration was terminated in 2012, suggesting the advisory business is no longer active in its former form. As a result, DKR Capital does not have a drug pipeline, therapeutic programs, or clinical development stage in the life sciences sense. For biotech analyst purposes, this entity is best categorized as a historical healthcare-oriented investment firm rather than a drug developer or healthcare operating company.